Showing 1,291 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Innovative HIV Gene Therapy Study Soon to Start Enrollment

Editor's pick
TheBody.com
6 February 2013
New & experimental HIV treatments

Suboptimal Suppression with Maraviroc plus a Boosted Protease Inhibitor?

Editor's pick
Journal Watch
5 February 2013
New & experimental HIV treatments

Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIV

Editor's pick
Gilead press release
25 January 2013
Pharmaceutical industry

Gilead petitions FDA over its Stribild AIDS med

Editor's pick
Pharmalot
25 January 2013
The search for a cure

Pitt team finds 'Achilles Heel' of key HIV replication protein

Editor's pick
Eurekalert (press release)
25 January 2013
The search for a cure

Stanford lab creates HIV-resistant cells

Editor's pick
San Francisco Chronicle
23 January 2013
Treatment outcomes & life expectancy

Australian researchers project that many HIV-positive people will run out of treatment options

News
22 January 2013
New & experimental HIV treatments

Researchers attack HIV's final defenses before drug-resistant mutations emerge

Editor's pick
Medical Xpress
17 January 2013
The search for an HIV prevention vaccine

New insights into HIV vaccine will improve drug development

Editor's pick
Science Daily
11 January 2013
Side effects

FDA clears Salix anti-diarrhoeal for HIV patients

Editor's pick
MarketWatch
2 January 2013
New & experimental HIV treatments

ViiV Files Regulatory Applications for New Integrase Inhibitor Dolutegravir

Editor's pick
AIDSMeds
19 December 2012
New & experimental HIV treatments

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Editor's pick
ViiV press release
18 December 2012
The search for an HIV prevention vaccine

Major Breakthrough in HIV Research: Swiss Vaccine Research Institute

Editor's pick
Business Wire
18 December 2012
HIV treatment for children & young people

DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs

Editor's pick
Eurekalert Inf Dis
12 December 2012
New & experimental HIV treatments

Six Promising HIV Drugs in the Pipeline

Editor's pick
The Body Pro
11 December 2012
New & experimental HIV treatments

FDA approves prescribing information update for EDURANT® (rilpivirine)

Editor's pick
Janssen press release
11 December 2012
New & experimental HIV treatments

Crucial step in AIDS virus maturation simulated for first time

Editor's pick
Science Daily
5 December 2012
The search for an HIV prevention vaccine

THERAVECTYS is granted authorization from the French and Belgian regulatory agencies to launch a Phase III clinical trial for its anti-HIV therapeutic vaccine candidate

Editor's pick
EATG
4 December 2012
People with limited treatment options

Redefining Expanded Access Programs for patients with MDR-HIV

Editor's pick
GMHC Treatment Issues
4 December 2012
HIV treatment

New fixed-dose combination pills measure up to Atripla - corrected version*

News
20 November 2012
New & experimental HIV treatments

Merck & Co and Gilead highlight new data at international HIV meeting

Editor's pick
The Pharma Letter
16 November 2012
New & experimental HIV treatments

Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients

Editor's pick
Bloomberg
14 November 2012
New & experimental HIV treatments

FDA approves new 800mg PREZISTA® (darunavir) tablet

Editor's pick
Janssen press release
12 November 2012
New & experimental HIV treatments

Is protease inhibitor monotherapy sufficient to keep HIV under control in the brain?

Editor's pick
CATIE
2 November 2012